Bio Key International Stock Performance
| BKYI Stock | USD 1.20 0.06 4.76% |
BIO Key holds a performance score of 7 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.04, which signifies a somewhat significant risk relative to the market. BIO Key returns are very sensitive to returns on the market. As the market goes up or down, BIO Key is expected to follow. Use BIO Key daily balance of power, price action indicator, as well as the relationship between the semi variance and treynor ratio , to analyze future returns on BIO Key.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in BIO Key International are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly conflicting basic indicators, BIO Key demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor 1:18 | Dividend Date 2020-11-20 | Last Split Date 2023-12-21 |
1 | Acquisition by James Sullivan of 1 shares of BIO Key at 1.4 subject to Rule 16b-3 | 12/31/2024 |
2 | Symbol Lookup | 01/02/2025 |
3 | New Jersey Based Biometric and Cyber Security Solutions Provider BIO-key to Present and Participate at DealFlows Atlantic City Microcap Conference Jan. 29th and... | 01/10/2025 |
4 | National Bank of Egypt Enhances Enterprise Security with Multi-Factor Authentication and Single Sign-On Solutions from BIO-key | 01/15/2025 |
5 | Three Higher Education Customers with 30,000 Users Migrate to BIO-keys PortalGuard IDaaS ... | 01/21/2025 |
6 | BIO-key Wins Major Contract Wyoming Education Dept Selects PortalGuard Platform - StockTitan | 01/27/2025 |
7 | BIO-key International, Inc. Sees Large Increase in Short Interest | 01/28/2025 |
8 | Acquisition by Michel Robert J of 1429 shares of BIO Key subject to Rule 16b-3 | 01/31/2025 |
9 | Acquisition by Knook Pieter Cornelis of 1429 shares of BIO Key subject to Rule 16b-3 | 02/06/2025 |
10 | Acquisition by James Sullivan of 2377 shares of BIO Key at 1.52 subject to Rule 16b-3 | 02/11/2025 |
11 | Whats Going On With BIO-Key International Stock | 03/13/2025 |
| Begin Period Cash Flow | 2.6 M |
BIO |
BIO Key Relative Risk vs. Return Landscape
If you would invest 92.00 in BIO Key International on December 17, 2024 and sell it today you would earn a total of 28.00 from holding BIO Key International or generate 30.43% return on investment over 90 days. BIO Key International is currently generating 1.3379% in daily expected returns and assumes 14.997% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than BIO, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
BIO Key Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BIO Key's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BIO Key International, and traders can use it to determine the average amount a BIO Key's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0892
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | BKYI | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.0 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.34 actual daily | 26 74% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average BIO Key is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BIO Key by adding it to a well-diversified portfolio.
BIO Key Fundamentals Growth
BIO Stock prices reflect investors' perceptions of the future prospects and financial health of BIO Key, and BIO Key fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BIO Stock performance.
| Return On Equity | -4.58 | ||||
| Return On Asset | -0.56 | ||||
| Profit Margin | (0.92) % | ||||
| Operating Margin | (1.45) % | ||||
| Current Valuation | 5.13 M | ||||
| Shares Outstanding | 3.11 M | ||||
| Price To Earning | (2.55) X | ||||
| Price To Book | 33.57 X | ||||
| Price To Sales | 0.61 X | ||||
| Revenue | 7.75 M | ||||
| Gross Profit | 3.44 M | ||||
| EBITDA | (7.85 M) | ||||
| Net Income | (8.52 M) | ||||
| Cash And Equivalents | 4.89 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 365.35 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 3.50 X | ||||
| Book Value Per Share | (0.58) X | ||||
| Cash Flow From Operations | (3.79 M) | ||||
| Earnings Per Share | (8.66) X | ||||
| Market Capitalization | 3.25 M | ||||
| Total Asset | 4.52 M | ||||
| Retained Earnings | (125.01 M) | ||||
| Working Capital | (591.23 K) | ||||
| Current Asset | 9.88 M | ||||
| Current Liabilities | 1.72 M | ||||
About BIO Key Performance
By evaluating BIO Key's fundamental ratios, stakeholders can gain valuable insights into BIO Key's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BIO Key has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BIO Key has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 29.59 | 28.11 | |
| Return On Tangible Assets | (2.47) | (2.59) | |
| Return On Capital Employed | (7.79) | (7.40) | |
| Return On Assets | (1.70) | (1.78) | |
| Return On Equity | (9.21) | (8.75) |
Things to note about BIO Key International performance evaluation
Checking the ongoing alerts about BIO Key for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BIO Key International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BIO Key is way too risky over 90 days horizon | |
| BIO Key may become a speculative penny stock | |
| BIO Key appears to be risky and price may revert if volatility continues | |
| BIO Key has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 7.75 M. Net Loss for the year was (8.52 M) with profit before overhead, payroll, taxes, and interest of 3.44 M. | |
| BIO Key International currently holds about 4.89 M in cash with (3.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| BIO Key has a poor financial position based on the latest SEC disclosures | |
| Latest headline from benzinga.com: Whats Going On With BIO-Key International Stock |
- Analyzing BIO Key's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BIO Key's stock is overvalued or undervalued compared to its peers.
- Examining BIO Key's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BIO Key's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BIO Key's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BIO Key's stock. These opinions can provide insight into BIO Key's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BIO Stock analysis
When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world |